Governor Tom Wolf had vowed to scrap the multi-tiered system put in place by his Republican predecessor. Advocates said the Corbett Administration's plan was too complex and hindered enrollment.
There’s a saying in government, “Elections have consequences.” In Pennsylvania, the consequences of last November’s election of Governor Tom Wolf took hold this week in the commonwealth’s Medicaid program.
Wolf, the only Democrat to oust an incumbent Republican governor last fall, had vowed to toss out then-Governor Tom Corbett’s complex Medicaid expansion effort, called Healthy PA, which was being phased in after long negotiations with CMS. The new governor moved immediately toward a more traditional expansion program, although the process took until September 1, 2015, to complete.
Dubbed HealthChoices, the new program involved the transfer of more than 1 million adult Medicaid enrollees into a single benefits package, which the Department of Human Services (DHS) said has expanded services for primary care, preventive care, and behavioral health.
The original expansion called for different tiers of benefits; the program made a distinction between existing Medicaid beneficiaries and enrollees earning between 100% and 138% of the federal poverty line—the new population added under the Affordable Care Act. Advocacy groups said the Corbett program had too many hurdles to enrollment and was not a good long-term platform.
"Medicaid expansion means that more Pennsylvanians have access to primary and preventative care. As a result, they will be able to see a doctor when they are able to see a doctor when they are sick, have better health outcomes, and be able to avoid costly trips to the emergency room," said DHS Secretary Ted Dallas.
Wolf converted Corbett’s program in phases:
· On April 27, 2015, he announced the transition of 120,000 beneficiaries from the Healthy PA plan to HealthChoices.
· On July 27, 2015, the Department of Human Services moved the remaining beneficiaries from HealthyPA’s private coverage option to HealthChoices. These enrollees had 30 days to select an insurance plan and were given “bridge” coverage until September 1, 2015.
· In a statement, the Pennsylvania DHS said that 440,000 enrollees have taken advantage of Medicaid expansion, and 216,000 newly eligible residents have signed up since April 27, 2015.
Advocates for the poor had protested many of Corbett’s original proposals and even a few that survived CMS scrutiny. Notably, Corbett did not succeed in gaining approval for a requirement that beneficiaries prove they are seeking a job or job training, an element that remains a point of contention among several Southern governors who have pondered expansion but face resistance from their legislatures.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More